Straits Times Index
3,264.81 -35.23 (-1.07%) S&P 500
5,187.70 +6.96 (+0.13%) Dow
38,884.26 +31.99 (+0.08%) Nasdaq
16,332.56 -16.69 (-0.10%) Bitcoin USD
62,302.26 -1,207.95 (-1.90%) CMC Crypto 200
1,290.51 -4.16 (-0.32%)
T2 Biosystems, Inc. (TTOO)
After hours:
- GlobeNewswire
T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease
Advances plan to launch T2Lyme Panel for detection of early Lyme diseaseFiled Pursuant to Rule 433Issuer Free Writing Prospectus dated May 6, 2024Relating to Preliminary Prospectus dated May 6, 2024Registration No. 333-278866 LEXINGTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has signed a non-binding letter of intent (“LOI”) to enter into a strat
- Insider Monkey
T2 Biosystems, Inc. (NASDAQ:TTOO) Q1 2024 Earnings Call Transcript
T2 Biosystems, Inc. (NASDAQ:TTOO) Q1 2024 Earnings Call Transcript May 6, 2024 T2 Biosystems, Inc. beats earnings expectations. Reported EPS is $-0.00266, expectations were $-2.2. TTOO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to the T2 Biosystems, […]
- Thomson Reuters StreetEvents
Q1 2024 T2 Biosystems Inc Earnings Call
Q1 2024 T2 Biosystems Inc Earnings Call
